These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37469197)

  • 1. Gene-level dissection of chromosome 3q locus amplification in squamous cell carcinoma of the lung using the nCounter assay.
    Jeon T; Oh UJ; Min J; Kim C
    Thorac Cancer; 2023 Sep; 14(26):2635-2641. PubMed ID: 37469197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A broad amplification pattern at 3q in squamous cell lung cancer--a fluorescence in situ hybridization study.
    Kettunen E; el-Rifai W; Björkqvist AM; Wolff H; Karjalainen A; Anttila S; Mattson K; Husgafvel-Pursiainen K; Knuutila S
    Cancer Genet Cytogenet; 2000 Feb; 117(1):66-70. PubMed ID: 10700870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma.
    Iijima Y; Seike M; Noro R; Ibi T; Takeuchi S; Mikami I; Koizumi K; Usuda J; Gemma A
    Int J Oncol; 2015 Feb; 46(2):505-12. PubMed ID: 25384882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugs.
    Brunelli M; Bria E; Nottegar A; Cingarlini S; Simionato F; Caliò A; Eccher A; Parolini C; Iannucci A; Gilioli E; Pedron S; Massari F; Tortora G; Borze I; Knuutila S; Gobbo S; Santo A; Tondulli L; Calabrò F; Martignoni G; Chilosi M
    PLoS One; 2012; 7(12):e49689. PubMed ID: 23236352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.
    Rekhtman N; Paik PK; Arcila ME; Tafe LJ; Oxnard GR; Moreira AL; Travis WD; Zakowski MF; Kris MG; Ladanyi M
    Clin Cancer Res; 2012 Feb; 18(4):1167-76. PubMed ID: 22228640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung.
    Chan AW; Chau SL; Tong JH; Chow C; Kwan JSH; Chung LY; Lung RW; Tong CY; Tin EK; Law PP; Law WT; Ng CSH; Wan IYP; Mok TSK; To KF
    J Thorac Oncol; 2019 Jul; 14(7):1213-1222. PubMed ID: 30978501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
    Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
    Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma.
    Björkqvist AM; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Tammilehto L; Mattson K; Vainio H; Knuutila S
    Genes Chromosomes Cancer; 1998 May; 22(1):79-82. PubMed ID: 9591638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.
    Lockwood WW; Chari R; Coe BP; Thu KL; Garnis C; Malloff CA; Campbell J; Williams AC; Hwang D; Zhu CQ; Buys TP; Yee J; English JC; Macaulay C; Tsao MS; Gazdar AF; Minna JD; Lam S; Lam WL
    PLoS Med; 2010 Jul; 7(7):e1000315. PubMed ID: 20668658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.
    Che J; Yue D; Zhang B; Zhang H; Huo Y; Gao L; Zhen H; Yang Y; Cao B
    Int J Med Sci; 2018; 15(4):339-351. PubMed ID: 29511369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma.
    Kacew AJ; Harris EJ; Lorch JH; Haddad RI; Chau NG; Rabinowits G; LeBoeuf NR; Schmults CD; Thakuria M; MacConaill LE; Hanna GJ
    Eur J Cancer; 2019 May; 113():1-9. PubMed ID: 30954880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese.
    Dong J; Jin G; Wu C; Guo H; Zhou B; Lv J; Lu D; Shi Y; Shu Y; Xu L; Chu M; Wang C; Zhang R; Dai J; Jiang Y; Yu D; Ma H; Zhao X; Yin Z; Yang L; Li Z; Deng Q; Cao S; Qin Z; Gong J; Sun C; Wang J; Wu W; Zhou G; Chen H; Guan P; Chen Y; Liu X; Liu L; Xu P; Han B; Bai C; Zhao Y; Zhang H; Yan Y; Liu J; Amos CI; Chen F; Tan W; Jin L; Wu T; Hu Z; Lin D; Shen H
    PLoS Genet; 2013; 9(1):e1003190. PubMed ID: 23341777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.
    McGowan M; Hoven AS; Lund-Iversen M; Solberg S; Helland Å; Hirsch FR; Brustugun OT
    Lung Cancer; 2017 Jan; 103():52-57. PubMed ID: 28024696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies.
    Ho HL; Kao HL; Yeh YC; Chou TY
    Diagn Pathol; 2019 Jun; 14(1):59. PubMed ID: 31221183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.
    Campbell JD; Alexandrov A; Kim J; Wala J; Berger AH; Pedamallu CS; Shukla SA; Guo G; Brooks AN; Murray BA; Imielinski M; Hu X; Ling S; Akbani R; Rosenberg M; Cibulskis C; Ramachandran A; Collisson EA; Kwiatkowski DJ; Lawrence MS; Weinstein JN; Verhaak RG; Wu CJ; Hammerman PS; Cherniack AD; Getz G; ; Artyomov MN; Schreiber R; Govindan R; Meyerson M
    Nat Genet; 2016 Jun; 48(6):607-16. PubMed ID: 27158780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.
    Kobayashi-Watanabe N; Sato A; Watanabe T; Abe T; Nakashima C; Sueoka E; Kimura S; Sueoka-Aragane N
    Lung Cancer; 2017 Aug; 110():35-41. PubMed ID: 28676216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma.
    Wada S; Noguchi T; Takeno S; Kawahara K
    Ann Surg Oncol; 2006 Jul; 13(7):961-6. PubMed ID: 16788758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung.
    Brass N; Rácz A; Heckel D; Remberger K; Sybrecht GW; Meese EU
    Cancer Res; 1997 Jun; 57(11):2290-4. PubMed ID: 9187134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis.
    Jiang T; Gao G; Fan G; Li M; Zhou C
    Lung Cancer; 2015 Jan; 87(1):1-7. PubMed ID: 25433983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.